Tonghua Dongbao Pharmaceutical Co., Ltd. (SHA:600867)

China flag China · Delayed Price · Currency is CNY
8.57
-0.19 (-2.17%)
May 20, 2026, 11:29 AM CST
Market Cap17.02B +21.6%
Revenue (ttm)3.04B +47.0%
Net Income1.24B
EPS0.61
Shares Out1.94B
PE Ratio14.45
Forward PE26.55
Dividend0.30 (3.47%)
Ex-Dividend DateJun 25, 2025
Volume12,056,541
Average Volume43,137,632
Open8.73
Previous Close8.76
Day's Range8.55 - 8.73
52-Week Range7.56 - 10.67
Beta0.22
RSI35.61
Earnings DateAug 24, 2026

About SHA:600867

Tonghua Dongbao Pharmaceutical Co., Ltd. researches, develops, produces, and markets pharmaceuticals in China. It offers human insulin injections; insulin glargine injections; insulin aspart injections; liraglutide injections; and proprietary Chinese medicine. The company also provides insulin pen and pen needles; and chronic disease management platform, a diabetes management platform for drug treatment, blood glucose monitoring, and patient education. In addition, it offers chemical drugs, such as repaglinide, sitagliptin phosphate, and metfor... [Read more]

Sector Healthcare
Founded 1985
Employees 3,410
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600867
Full Company Profile

Financial Performance

Financial Statements